Address: 2nd Floor, Building A
345 Rivonia Boulevard
Edenburg, Rivonia
Sandton 2128
South Africa
Tel: +27 (11) 202-0500
Web: http://www.novonordisk.com/
Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs more than 29,300 employees in 76 countries, and markets its products in 179 countries.
Novo Nordisk is a focused healthcare company and a world leader in diabetes care.
We believe action defines leadership.
The status quo is just not good enough. We are actively working to change the course of the diabetes pandemic, improve the daily lives of people with diabetes, and to expand the possibilities for people with hemophilia. Innovation and personal passion are the hallmarks of how we operate.
Our company’s history is full of firsts, and we will continue to tap that well of innovation to not only develop ever-more effective treatment options for the patients we serve but also innovation in education, leadership and advocacy.
Personal passion about the well-being of people with chronic illness has always been at the heart of our company. Our roots reach far back to a man driven to find an innovative treatment for his wife, in 1923.
We carry that same passion and commitment beyond diabetes into our work for people with haemophilia, growth disorders and women requiring hormone therapy.
Since that start, the company’s care for the individual’s well-being blossomed into a deep sense of responsibility for all of society. An early adopter of the triple bottom line approach to business, Novo Nordisk remains a leading proponent of balancing its environmental impact, social contribution and financial results.
The story of Novo Nordisk South Africa began in 1959 in Johannesburg. It was among the first affiliates outside of Denmark, with insulin and anti-infectives produced locally. To what extent…
Writing in the February 2024 edition of the DIA Global Forum magazine, Verena Pfaffinger and Ilona Baraniak-Lang of PharmaLex examine how the drug shortages seen in the global south during…
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
Lenias Hwenda of Medicines for Africa examines the true impact of access to medicine initiatives in Africa, noting that many of the measures takes are often cosmetic and leave a…
See our Cookie Privacy Policy Here
